コンテンツへスキップ
Merck

1494909

USP

Pantoprazole Related Compound A

United States Pharmacopeia (USP) Reference Standard

別名:

Pantoprazole sulfone, 5-(Difluoromethoxy)-2-{[(3,4-dimethoxy-2-pyridinyl)methyl]sulfone}-1H-benzimidazole

ログイン組織・契約価格を表示する


About This Item

実験式(ヒル表記法):
C16H15F2N3O5S
CAS番号:
分子量:
399.37
Beilstein:
9430498
UNSPSCコード:
41116107
NACRES:
NA.24

グレード

pharmaceutical primary standard

APIファミリー

pantoprazole

メーカー/製品名

USP

アプリケーション

pharmaceutical (small molecule)

フォーマット

neat

InChI

1S/C16H15F2N3O5S/c1-24-13-5-6-19-12(14(13)25-2)8-27(22,23)16-20-10-4-3-9(26-15(17)18)7-11(10)21-16/h3-7,15H,8H2,1-2H3,(H,20,21)

InChI Key

FCJYMBZQIJDMMM-UHFFFAOYSA-N

類似した製品をお探しですか? 訪問 製品比較ガイド

アプリケーション


  • Transcriptional profiling for drug repurposing in glioblastoma: This study utilized transcriptional profiling to identify therapeutic targets and repurpose drugs, including pantoprazole-related compounds, for treatment in glioblastoma. This approach underscores the utility of pantoprazole impurities in exploring new therapeutic avenues in pharmaceutical reference material research (Roddy et al., 2023).

  • Gastroprotective agent utilization: A drug utilization study in medicine and surgery wards highlighted the significant role of pantoprazole and its related compounds in managing gastrointestinal protection. This research emphasizes the importance of pantoprazole as a proton pump inhibitor and its impurities in ensuring the efficacy and safety of gastroprotective therapies (Koyani et al., 2023).

  • Synthesis and analysis of pantoprazole sodium sesquihydrate-related compound E: This study explored the synthesis and mechanism of formation of a specific pantoprazole-related compound, offering insights into the chemical stability and quality control of pantoprazole as a pharmaceutical ingredient. Such research is crucial for enhancing analytical methods in pharmaceutical research and ensuring drug safety and efficacy (Yari et al., 2019).

アナリシスノート

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

その他情報

Sales restrictions may apply.

保管分類コード

11 - Combustible Solids

WGK

WGK 3

引火点(°F)

Not applicable

引火点(℃)

Not applicable


試験成績書(COA)

製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

E Doyle et al.
Journal of chromatography, 527(1), 67-77 (1990-04-27)
This paper describes two fully automated assays. One for zaprinast, a cGMP specific phosphodiesterase inhibitor, which uses the Gilson-Advanced Automated Sample Processor combination, and the other for an H+/K+ ATPase inhibitor and its sulphone metabolite, which uses direct injection. Both
Dafang Zhong et al.
The Journal of pharmacy and pharmacology, 57(3), 341-349 (2005-04-06)
We have investigated the metabolism of pantoprazole and have provided an explanation for the formation mechanism of its metabolites. Metabolites found in the urine of rats after oral administration of pantoprazole sodium (25 mg kg(-1)) were analysed by liquid chromatography/ion

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)